United Therapeutics
United Therapeutics is an established biotechnology firm focused on pulmonary arterial hypertension and related rare cardiopulmonary diseases, with additional long-term activity in organ manufacturing and transplant-related technologies.
- Biotechnology Firms
Overview
United Therapeutics is an established biotechnology firm focused on pulmonary arterial hypertension and related rare cardiopulmonary diseases, with additional long-term activity in organ manufacturing and transplant-related technologies.
The company’s strength lies in a durable specialty franchise. Pulmonary arterial hypertension is a serious rare disease requiring specialized physicians, long-term treatment, and complex care management. United Therapeutics has built a strong commercial position within this focused therapeutic area.
United Therapeutics is included in 2 2026 ranking categories. Its highest classification is Tier II. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.
Firm facts
| Public identity | United Therapeutics |
| Founded | 1996 |
| Company type | Public-benefit biopharmaceutical company |
| Co-headquarters | Silver Spring, Maryland, and Research Triangle Park, North Carolina, United States |
| Primary focus | Biotechnology Firms |
Contents
- Principal activities
- Sector and mandate coverage
- Market position
- Competitive context
- Leadership and governance
- Corporate and public information
- Additional published ranking appearances
- Company structure and assessed businesses
- Rankings and recognition
- Related Economy analysis
- Related institutions and subjects
- Sources and data transparency
Principal activities
The company’s strength lies in a durable specialty franchise. Pulmonary arterial hypertension is a serious rare disease requiring specialized physicians, long-term treatment, and complex care management. United Therapeutics has built a strong commercial position within this focused therapeutic area.
Core capability
Biotechnology Firms
Client relevance
Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.
Execution and verification
Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.
Sector and mandate coverage
Primary category
Biotechnology Firms
Institutional context
Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.
Market position
United Therapeutics’ rare disease franchise, commercial durability, and advanced therapeutic ambitions support its position among established biotechnology firms.
United Therapeutics is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier II.
Competitive context
The relevant peer set varies by category, geography, client segment and mandate. United Therapeutics should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.
Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.
Leadership and governance
Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.
Corporate and public information
The public-facing organization is identified here as United Therapeutics. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.
Corporate and disclosure information
| Organization | United Therapeutics |
| Co-headquarters | Silver Spring, Maryland, and Research Triangle Park, North Carolina, United States |
| Verification note | Confirm legal entity, licenses, offices and engagement terms directly before appointment or use. |
Additional published ranking appearances
These entries retain the edition, classification and assessed business name published in the source. Historical entries describe that edition, including businesses whose ownership or name later changed.
| Published ranking | Edition / tier | Assessed business |
|---|---|---|
| Top 20 Biotechnology Firms 2025 | 2025 · Tier II | United Therapeutics |
| Top 20 Specialty Pharma Companies 2025 | 2025 · Tier II | United Therapeutics |
| Top 20 Biotechnology Firms 2024 | 2024 · Tier II | United Therapeutics |
| Top 20 Specialty Pharma Companies 2024 | 2024 · Tier II | United Therapeutics |
| Top 20 Biotechnology Firms 2023 | 2023 · Tier II | United Therapeutics |
| Top 20 Specialty Pharma Companies 2023 | 2023 · Tier II | United Therapeutics |
Company structure and assessed businesses
United Therapeutics Corporation develops pharmaceutical therapies and technologies intended to expand transplantable-organ availability. It converted to a Delaware public benefit corporation in 2021. The short and full corporate-name profiles concern the same biotechnology business.
Primary sources: company reference 1.
Assessed business: United Therapeutics Corporation
United Therapeutics Corporation is profiled in The Economy Rankings across Employers for Research & Innovation Careers, Pharmaceutical & Biotechnology Employers, Employers for Family-Friendly Benefits and other categories listed below.
Business-specific facts retained from the earlier United Therapeutics Corporation assessment; dates and locations refer to that business scope.
| Assessed U.S. headquarters / base | Silver Spring, MD, US |
| Reported business origins | 1996 |
| Origins (qualified) | 1996 |
The category profiles below describe the named businesses, products, programmes or employee groups assessed in the linked rankings. Their scope follows each source.
Top 30 Employers for Work-Life Balance 2027 — United Therapeutics Corporation
United Therapeutics identifies family support within its benefits framework, including childcare tied to named main facilities. Other arrangements reach a broader US employee population. The location distinction is retained: a facility-based service is a concrete provision, but it is not a universal on-site entitlement for every employee wherever they work. Education support provides separate employment context.
Great Place To Work’s US employee profile, updated April 2026, reports 95% overall workplace endorsement. This supplies broad employee-experience evidence for the identified national cohort. The percentage is not presented as a separately measured work-life satisfaction result, working-hours record or benefit-utilization rate.
- Employing entity / assessed group: United Therapeutics Corporation (assessed U.S. employing group)
- Assessed workforce: US direct employees in the provider cohort; role/status conditions retained.
- Assessed U.S. headquarters / base: Silver Spring, MD, US
- Reported business origins: 1996
Top 30 Employers for Research & Innovation Careers 2027 — United Therapeutics Corporation
United Therapeutics supports scientific employment through education reimbursement and practical workforce arrangements. Its employee record also documents green-chemistry work intended to reduce hazardous substances in processing. That activity connects scientific practice with attention to the working environment, offering more specific context than a general statement that research is central to the business.
The benefits framework identifies family support, including childcare tied to named main facilities. Those provisions can matter to employees sustaining a professional career, but a campus facility is not represented as available physically at every location. The green-chemistry example describes an implemented approach without establishing a comparative incident rate or a uniform reduction in laboratory exposure.
- Assessed workforce: US employees in documented scientific/research-development work and professional support; role and programme eligibility applies.
Top 30 Employers for Family-Friendly Benefits 2027 — United Therapeutics
United Therapeutics identifies onsite childcare through Bright Horizons for employees at its Silver Spring and Durham facilities. The named locations make the family-care infrastructure concrete rather than universally assumed. For employees able to use the facilities, care near the workplace can be a distinct part of organizing working life.
The physical service is tied to those campuses and applicable eligibility. Other US employees are not described as having an onsite facility merely because they work for the same employer. The current benefits record and family-support account document the provision alongside other employee arrangements. This supplies a practical implementation setting distinct from a general statement of family values.
- Assessed workforce: US benefits-eligible direct employees; plan conditions apply; contractors excluded
- Origins (qualified): 1996
Top 30 Employers for Paid Leave Benefits 2027 — United Therapeutics
United Therapeutics’ US benefits provide full-time employees up to nineteen PTO days in the first employment year. The schedule separately identifies eleven paid holidays, varying by office location. Accrual and service progression affect what an employee can actually use during a particular year.
PTO accrual increases by one day for each completed year of service, up to a maximum of twenty-nine days. This is an accrual structure rather than an unconditional first-day deposit of the maximum. The current employee-benefits record sets out the annual progression and local holiday distinction. It supplies concrete operating terms for planning time away within the stated full-time population.
Top 30 Pharmaceutical & Biotechnology Employers 2027 — United Therapeutics Corporation
United Therapeutics publishes a benefits framework that includes education reimbursement and support for employees’ families. On-site childcare is tied to named main facilities, while other family-support arrangements reach a broader U.S. population. Its employer profile also documents green-chemistry work intended to reduce hazardous substances in processing, linking scientific activity with attention to the working environment.
Great Place To Work’s U.S. profile, updated April 2026, reports 95% overall workplace endorsement. A published employee item records 96% agreement: “I'm proud to tell others I work here.”
- Assessed workforce: U.S. directly employed workforce in provider cohort; contractors and unassessed foreign affiliates excluded.
| Ranking | Edition / classification | Assessed scope |
|---|---|---|
| Employers for Research & Innovation Careers | 2027 · Tier II | US employees in documented scientific/research-development work and professional support; role and programme eligibility applies. |
| Pharmaceutical & Biotechnology Employers | 2027 · Tier I · position 3 | U.S. directly employed workforce in provider cohort; contractors and unassessed foreign affiliates excluded. |
| Employers for Family-Friendly Benefits | 2027 · Tier II | US benefits-eligible direct employees; plan conditions apply; contractors excluded |
| Employers for Paid Leave Benefits | 2027 · Tier II | US benefits-eligible direct employees; plan conditions apply; contractors excluded |
| Employers for Work-Life Balance | 2027 · Tier II | US direct employees in the provider cohort; role/status conditions retained. |
Rankings and recognition
Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.
Related Economy analysis
Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:
- Healthcare Rankings and the New Economics of Expertise
- Healthcare Market Structure Is Opening a New Lane for Specialist Providers
- Healthcare Rankings and the New Geography of Distributed Care
Related institutions and subjects
Sources and data transparency
Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.
- Healthcare Ranking — Top 30 Biotechnology Firms 2026 — 2026 inclusion and tier classification.
- Healthcare Ranking — Top 30 Specialty Pharma Companies 2026 — 2026 inclusion and tier classification.
- The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
- The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
- The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.
Corrections and Updates
Factual corrections, updated institutional information, and supporting references may be submitted through The Economy Portal. All proposed changes are subject to editorial verification before publication.